SeaCrest Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

SeaCrest Wealth Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Buy	+4,111	New	+$209K	0.02%	524
2026 Q1	–	Sell	-3,536	Closed	-$227K	–	658
2025 Q4	$227K	Hold	3,536	–	–	0.02%	544
2025 Q3	$214K	Sell	3,536 -806	-19%	-$49.3K	0.02%	579
2025 Q2	$272K	Hold	4,342	–	–	0.03%	483
2025 Q1	$261K	Hold	4,342	–	–	0.03%	534
2024 Q4	$253K	Hold	4,342	–	–	0.03%	543
2024 Q3	$257K	Hold	4,342	–	–	0.03%	541
2024 Q2	$243K	Sell	4,342 -450	-9%	-$25.2K	0.03%	526
2024 Q1	$281K	Hold	4,792	–	–	0.03%	463
2023 Q4	$255K	Sell	4,792 -179	-4%	-$8.74K	0.03%	504
2023 Q3	$241K	Sell	4,971 -30	-0.6%	-$1.59K	0.03%	518
2023 Q2	$282K	Buy	5,001 +135	+3%	+$7.43K	0.04%	481
2023 Q1	$263K	Sell	4,866 -3	-0.1%	-$160	0.04%	501
2022 Q4	$256K	Sell	4,869 -63	-1%	-$3.2K	0.04%	489
2022 Q3	$233K	Hold	4,932	–	–	0.04%	498
2022 Q2	$249K	Buy	4,932 +1,122	+29%	+$61.2K	0.03%	526
2022 Q1	$232K	Sell	3,810 -44	-1%	-$2.62K	0.03%	604
2021 Q4	$254K	Hold	3,854	–	–	0.03%	565
2021 Q3	$242K	Sell	3,854 -94	-2%	-$6K	0.03%	561
2021 Q2	$237K	Sell	3,948 -6	-0.2%	-$347	0.03%	581
2021 Q1	$218K	Buy	3,954 +270	+7%	+$15K	0.03%	575
2020 Q4	$201K	Sell	3,684 -534	-13%	-$27.9K	0.03%	568
2020 Q3	$210K	Sell	4,218 -1,644	-28%	-$79.6K	0.03%	500
2020 Q2	$259K	Sell	5,862 -264	-4%	-$11.3K	0.04%	444
2020 Q1	$230K	Buy	6,126 +1,002	+20%	+$42.2K	0.05%	399
2019 Q4	$226K	Buy	+5,124	New	+$215K	0.04%	466
2019 Q3	–	Sell	-5,796	Closed	-$233K	–	551
2019 Q2	$233K	Sell	5,796 -1,800	-24%	-$68.1K	0.05%	439
2019 Q1	$293K	Hold	7,596	–	–	0.05%	367
2018 Q4	$253K	Buy	7,596 +2,160	+40%	+$74.8K	0.05%	370
2018 Q3	$206K	Buy	5,436 +3,486	+179%	+$124K	0.03%	493
2018 Q2	$65K	Buy	+1,950	New	+$63.5K	0.01%	881

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

SeaCrest Wealth Management's IHI Position: Q2 2026 in Review

SeaCrest Wealth Management opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 4,111 shares worth $203K. The stake represents 0.02% of the portfolio and ranks #524 among its holdings. This is a return to the name: SeaCrest Wealth Management previously reported a position in IHI as recently as Q4 2025.

SeaCrest Wealth Management first reported a position in IHI in Q2 2018 and has held it in 31 quarters since. The position peaked at $293K in Q1 2019. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

SeaCrest Wealth Management held 4,111 shares of iShares US Medical Devices ETF worth $203K as of Q2 2026.
iShares US Medical Devices ETF was a new SeaCrest Wealth Management position in Q2 2026.
iShares US Medical Devices ETF made up 0.02% of SeaCrest Wealth Management's portfolio in Q2 2026, its #524 holding.
SeaCrest Wealth Management first reported a position in iShares US Medical Devices ETF in Q2 2018 and has held it in 31 quarters since.
SeaCrest Wealth Management's iShares US Medical Devices ETF position peaked at $293K in Q1 2019.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.